Evidence map›Paper›PMID 41310641›Full record

ArticleRespiratory research2025

Correction: IGF1R deficiency mitigates acute lung injury by promoting anti-inflammatory transcriptional profiles.

Alfredo Urtubia, Sergio Piñeiro-Hermida, Elvira Alfaro-Arnedo, Judith Beni-Ledesma, Marta Canalejo, María de Toro, José García Pichel, Icíar P López

Abstract readPublished Erratum
In one paragraph

Article in Respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Alfredo UrtubiaLung Cancer and Respiratory Diseases Unit, Center for Biomedical Research of La Rioja (CIBIR)Fundación Rioja Salud, Logroño, Spain.
Sergio Piñeiro-HermidaTelomeres and Tumor Microenvironment Unit, Fundación Rioja Salud (CIBIR), Logroño, Spain.
Elvira Alfaro-ArnedoLung Cancer and Respiratory Diseases Unit, Center for Biomedical Research of La Rioja (CIBIR)Fundación Rioja Salud, Logroño, Spain.
Judith Beni-LedesmaLung Cancer and Respiratory Diseases Unit, Center for Biomedical Research of La Rioja (CIBIR)Fundación Rioja Salud, Logroño, Spain.
Marta CanalejoLung Cancer and Respiratory Diseases Unit, Center for Biomedical Research of La Rioja (CIBIR)Fundación Rioja Salud, Logroño, Spain.
María de ToroGenomics and Bioinformatics Core Facility, Center for Biomedical Research of La Rioja (CIBIR), Fundación Rioja Salud, Logroño, Spain.
José García PichelLung Cancer and Respiratory Diseases Unit, Center for Biomedical Research of La Rioja (CIBIR)Fundación Rioja Salud, Logroño, Spain. jgpichel@riojasalud.es.
Icíar P LópezLung Cancer and Respiratory Diseases Unit, Center for Biomedical Research of La Rioja (CIBIR)Fundación Rioja Salud, Logroño, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41310641
PMCPMC12659216

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.